-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $8 Price Target

Benzinga·06/04/2025 11:11:35
Listen to the news
HC Wainwright & Co. analyst Andres Maldonado reiterates ImmunityBio (NASDAQ:IBRX) with a Buy and maintains $8 price target.